Meningeal Neoplasms - 25 Studies Found
Terminated |
: Depocyt® With Sorafenib in Neoplastic Meningitis : Neoplastic Meningitis : 2009-08-24 :
|
Completed |
: A Pilot Study of Bevacizumab for Neoplastic Meningitis : Neoplastic Meningitis : 2009-06-18 : Drug: Bevacizumab 10 mg/kg by vein over about 1 hour, every 2 weeks. |
Completed |
: Phase 1 Intrathecal Topotecan for Neoplastic Meningitis : Neoplastic Meningitis : 2007-12-21 :
|
Terminated |
: DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis : Neoplastic Meningitis : 2007-08-13 :
|
Terminated |
: Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine :
: 2003-12-16 : Drug: Gemcitabine Schedule |
Recruiting |
: Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid Tumors : Leptomeningeal Metastasis : 2017-03-05 :
|
Not yet recruiting |
: Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis : Meningeal Carcinomatosis : 2015-10-26 : Drug: methotrexate The quantity of methotrexate is different in the two groups. |
Recruiting |
: Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM) : Leptomeningeal Metastasis : 2014-02-21 |
Recruiting |
: Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors :
: 2017-03-08 : Drug: Selumetinib Continuous twice daily dosing; oral agent |
Not yet recruiting |
: Phase II Study Of Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas : Meningioma : 2017-02-22 : Drug: AZD2014 AZD2014 is a dual mTORC1/mTORC2 inhibitor |